Status:

ACTIVE_NOT_RECRUITING

European Multicenter Validation of PCaVision: A Head-to-Head Diagnostic Accuracy Study Comparing Multiparametric Transrectal Ultrasound to MRI for Clinically Significant Prostate Cancer Detection

Lead Sponsor:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborating Sponsors:

Angiogenesis Analytics

Conditions:

Prostate Cancer

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to learn if a new ultrasound-based imaging method (PCaVision) can accurately detect clinically significant prostate cancer in adult men (18 years and older) who are ...

Detailed Description

Rationale The incidence of prostate cancer (PCa) has increased over the years. To diagnose PCa, histopathological confirmation is required. Different diagnostic pathways are currently available. Syste...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • male
  • 18 years of age or older
  • scheduled for evaluation by prostate MRI due to:
  • suspicious digital rectal examination (DRE) and/or
  • Elevated serum PSA levels, or as part of active surveillance (AS) follow-up
  • Have provided written informed consent
  • Exclusion criteria:
  • Active urinary tract infection or prostatitis
  • A history of cardiac right-to-left shunt
  • Allergy to sulphur hexafluoride or any other ingredient in the ultrasound contrast agent SonoVue
  • Current treatment with dobutamine
  • Severe pulmonary hypertension (pulmonary artery pressure \> 90 mmHg), uncontrolled systemic hypertension, or respiratory distress syndrome
  • Any other contraindication to MRI or 3D mpUS imaging
  • Inability to understand the language of the patient information (i.e., language barrier)
  • Previous treatment with focal therapy for prostate cancer (e.g., HIFU, cryotherapy, laser ablation, etc.)

Exclusion

    Key Trial Info

    Start Date :

    April 1 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2027

    Estimated Enrollment :

    806 Patients enrolled

    Trial Details

    Trial ID

    NCT06935487

    Start Date

    April 1 2025

    End Date

    May 1 2027

    Last Update

    April 20 2025

    Active Locations (10)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (10 locations)

    1

    Institut Paoli- Calmettes

    Marseille, France

    2

    L'Institut Mutualiste Montsouris

    Paris, France

    3

    University Klinikum Bonn

    Bonn, Germany

    4

    Martini-Klinik am UKE

    Hamburg, Germany